MF

Mohd Fahim Akmal Khan

Active Director Additional Director DIN 10648630
DIN 10648630 First appointment May 2024
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Mohd Fahim Akmal Khan

Data last updated:

Mohd Fahim Akmal Khan is an Additional Director at Dn World Diagnostics Private Limited (since 2024).

DIN 10648630
Primary Designation Additional Director
First Appointment 30 May 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Dn World Diagnostics Private Limited U86905DL2024PTC428745
Additional Director30 May 20242024Active

Board colleagues of Mohd Fahim Akmal Khan

Directorship timeline

Open interactive timeline →
Dn World Diagnostics Private Limited
Premium access

Shareholding and investment profile for Mohd Fahim Akmal Khan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mohd Fahim Akmal Khan

Mohd Fahim Akmal Khan currently holds 1 directorship: Dn World Diagnostics Private Limited (Additional Director, since 30 May 2024).

Mohd Fahim Akmal Khan was first appointed on 30 May 2024 as Additional Director at Dn World Diagnostics Private Limited.

The current boards of Mohd Fahim Akmal Khan's companies include Hemant Kumar (Dn World Diagnostics Private Limited), Mahipal Singh (Dn World Diagnostics Private Limited), Priyanka (Dn World Diagnostics Private Limited), Rakesh Gujjar (Dn World Diagnostics Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available